More progress made in identifying aggressive prostate cancer

Steps forward in treating prostate cancerResearchers at the University of Michigan say they have made strides in their ability to identify aggressive prostate cancer.

The scientists have discovered small molecules called metabolites that may point to more aggressive forms of the cancer, potentially allowing physicians to provide better treatment.

Findings published in the journal Nature reveal that one particular metabolite – sarcosine – was one of the strongest indicators of faster-growing tumors. Sarcosine can be detected in a patient’s urine.

“One of the biggest challenges we face in prostate cancer is determining if the cancer is aggressive,” said study author Dr. Arul Chinnaiyan. “With this research, we have identified a potential marker for the aggressive tumors.”

The scientists said the findings are preliminary and more research is needed to confirm the marker’s potential.

Approximately 186,320 people will be diagnosed with prostate cancer this year, according to predictions by the American Cancer Society.

Some people turn to nutritional supplements as a way to help ensure they maintain a healthy prostate.
ADNFCR-1960-ID-19021532-ADNFCR